203 related articles for article (PubMed ID: 23902145)
1. The role of antimicrobial stewardship in curbing carbapenem resistance.
Bogan C; Marchaim D
Future Microbiol; 2013 Aug; 8(8):979-91. PubMed ID: 23902145
[TBL] [Abstract][Full Text] [Related]
2. [Approach to directed therapy after knowledge of the isolate: carbapenemase-producing Enterobacteriaceae, multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii].
Martínez JA
Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():31-4. PubMed ID: 27608310
[TBL] [Abstract][Full Text] [Related]
3. Multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii infections among hospitalized patients: risk factors and outcomes.
Shanthi M; Sekar U
J Assoc Physicians India; 2009 Sep; 57():636, 638-40, 645. PubMed ID: 20214000
[TBL] [Abstract][Full Text] [Related]
4. Carbapenem-Resistant Non-Glucose-Fermenting Gram-Negative Bacilli: the Missing Piece to the Puzzle.
Gniadek TJ; Carroll KC; Simner PJ
J Clin Microbiol; 2016 Jul; 54(7):1700-1710. PubMed ID: 26912753
[TBL] [Abstract][Full Text] [Related]
5. Controlling endemic multidrug-resistant Acinetobacter baumannii in Intensive Care Units using antimicrobial stewardship and infection control.
Cheon S; Kim MJ; Yun SJ; Moon JY; Kim YS
Korean J Intern Med; 2016 Mar; 31(2):367-74. PubMed ID: 26874513
[TBL] [Abstract][Full Text] [Related]
6. Control of simultaneous outbreaks of carbapenemase-producing enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and Prevention 2012 carbapenemase-resistant Enterobacteriaceae Toolkit.
Enfield KB; Huq NN; Gosseling MF; Low DJ; Hazen KC; Toney DM; Slitt G; Zapata HJ; Cox HL; Lewis JD; Kundzins JR; Mathers AJ; Sifri CD
Infect Control Hosp Epidemiol; 2014 Jul; 35(7):810-7. PubMed ID: 24915208
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
Lee YL; Chen YS; Toh HS; Huang CC; Liu YM; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Liu CE; Hsueh PR
Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S29-36. PubMed ID: 22749056
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial resistance and stewardship in long-term care settings.
Moro ML; Gagliotti C
Future Microbiol; 2013 Aug; 8(8):1011-25. PubMed ID: 23902147
[TBL] [Abstract][Full Text] [Related]
9. Controlling Nosocomial Transmission of Drug-Resistant Pathogens at Different Endemic Stages in a Resource-Limited Setting.
Carlson AL; Pruetpongpun N; Buppajarntham A; Apisarnthanarak A
Infect Control Hosp Epidemiol; 2016 Sep; 37(9):1114-6. PubMed ID: 27322523
[No Abstract] [Full Text] [Related]
10. Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration.
Landman D; Babu E; Shah N; Kelly P; Olawole O; Bäcker M; Bratu S; Quale J
J Antimicrob Chemother; 2012 Jun; 67(6):1427-31. PubMed ID: 22378678
[TBL] [Abstract][Full Text] [Related]
11. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
Zavascki AP; Soares FC; Superti SV; Silbert S; Silva FM; Barth AL
Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093
[No Abstract] [Full Text] [Related]
12. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
Burgess DS; Frei CR
J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
[TBL] [Abstract][Full Text] [Related]
13. Associations between carbapenem use, carbapenem-resistant Pseudomonas aeruginosa, and carbapenem-resistant Acinetobacter baumannii.
Apisarnthanarak A; Jitpokasem S; Mundy LM
Infect Control Hosp Epidemiol; 2013 Nov; 34(11):1235-7. PubMed ID: 24113616
[No Abstract] [Full Text] [Related]
14. Rapid Blue-Carba test: reduction in the detection time of carbapenemases performed from a 4-hour bacterial lawn.
Nastro M; Ayora M; García S; Vay C; Famiglietti Á; Rodriguez CH
J Chemother; 2017 Jun; 29(3):150-153. PubMed ID: 27347714
[TBL] [Abstract][Full Text] [Related]
15. Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies.
Abbott I; Cerqueira GM; Bhuiyan S; Peleg AY
Expert Rev Anti Infect Ther; 2013 Apr; 11(4):395-409. PubMed ID: 23566149
[TBL] [Abstract][Full Text] [Related]
16. The emerging threat from carbapenem-resistant enterobacteriaceae.
Landry J; Hurst H
Nurs Womens Health; 2013 Dec; 17(6):519-24. PubMed ID: 24589052
[TBL] [Abstract][Full Text] [Related]
17. Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa.
Rice LB
Clin Infect Dis; 2006 Sep; 43 Suppl 2():S100-5. PubMed ID: 16894511
[TBL] [Abstract][Full Text] [Related]
18. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
[TBL] [Abstract][Full Text] [Related]
19. [Multiresistant Gram-negative bacterial infections: Enterobacteria, Pseudomonas aeruginosa, Acinetobacter baumannii and other non-fermenting Gram-negative bacilli].
Fariñas MC; Martínez-Martínez L
Enferm Infecc Microbiol Clin; 2013; 31(6):402-9. PubMed ID: 23684390
[TBL] [Abstract][Full Text] [Related]
20. Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections.
Kunz AN; Brook I
Chemotherapy; 2010; 56(6):492-500. PubMed ID: 21099222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
